Remedy Meds review

The description of the microdose here is the best found anywhere. Most sellers offering a low dose describe it as a smaller number and leave it there; this one describes the actual protocol — the same medication at half the dose, split into two injections a week rather than one — and gives the reasoning, which is tolerance rather than saving money. It also says plainly that stepping up to a full plan is available whenever you want it, so the low dose is offered as a genuine starting point rather than a cheaper tier you might get stranded in. Twice-weekly splitting is a specific clinical choice, and seeing it named and explained is genuinely useful, because it is the sort of thing most readers only encounter in a forum. Then the page stops. There is no price for the microdose plan, none for the standard plans, and the pricing and plans pages produce nothing at all. So you are told exactly what the protocol is and nothing whatever about what it costs — the reverse of the usual failure on this site, and no more useful for planning. One practical detail is published: shipments arrive every 28 days, so a year holds thirteen of them rather than twelve.

Vs median

Not comparable — no figure is published before intake

Market

$59–$1300/mo is the full published spread in our ranking

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Remedy Meds dispenses through a Not named (stated as licensed U.S. pharmacies) facility. No bloodwork is required before you start. A clinician review is included in the price.

The description of the microdose here is the best found anywhere. Most sellers that offer a low dose describe it as a smaller number; this one describes the actual protocol — the same medication at half the dose, split into two injections a week rather than one — and gives the reasoning, which is tolerance rather than price. It also says plainly that stepping up to a full plan is available whenever the patient wants it, so the low dose is presented as a real starting point rather than a cheaper tier someone might get stuck in. Twice-weekly splitting is a specific clinical choice and seeing it named is genuinely useful. Then the page stops. There is no price for the microdose plan, none for the standard plans, and the pricing and plans pages produce nothing at all. So a reader is told exactly what the protocol is and nothing about what it costs, which is the reverse of the usual failure here and no more useful. One practical detail that is published: shipments arrive every 28 days, so a year holds thirteen of them rather than twelve.

No price is published for the microdose plan, or for any other plan.

• The pricing and plans pages produce nothing at all.
• A 28-day cycle means thirteen shipments a year, not twelve.

Remedy Meds is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Titrating up from a microdose
• Titration planner
• The true annual cost of a plan